1. |
Nitta D, Mitani H, Ishimura R, et al. Deep vein thrombosis risk stratification. Int Heart J, 2013, 54(3): 166-170.
|
2. |
Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med, 2008, 149(10): 698-707.
|
3. |
Burgazli KM, Atmaca N, MericIiler M, et al. Deep vein thrombosis and novel oral anticoagulants: a clinical review. Eur Rev Med Pharmacol Sci, 2013, 17(23): 3123-3131.
|
4. |
White RH. The epidemiology of venous thromboembolism. Circulation, 2003, 107(23 Suppl 1): I4-I8.
|
5. |
Vasquez MA, Rabe E, McLafferty RB, et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg, 2010, 52(5): 1387-1396.
|
6. |
张昌列, 宋志红. 瑞替普酶治疗下肢深静脉血栓形成的临床观察. 重庆医学, 2015, 44(2): 207-208, 211.
|
7. |
Stein PD, Matta F. Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism. Crit Care Clin, 2011, 27(4): 907-932.
|
8. |
Ho WK, Hankey GJ, Eikelboom JW. The incidence of venous thromboembolism: a prospective, community-based study in Perth, Western Australia. Med J Aust, 2008, 189(3): 144-147.
|
9. |
刘杰, 费蕾, 周乐红, 等. 下肢深静脉血栓形成后并发肺栓塞相关危险因素分析. 临床外科杂志, 2013, 21(3): 169-171.
|
10. |
Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev, 2009, 23(5): 225-229.
|
11. |
Timp JF, Braekkan SK, Versteeg HH, et al. Epidemiology of cancer-associated venous thrombosis. Blood, 2013, 122(10): 1712-1723.
|
12. |
王雪钢, 蒋岚杉, 白斗, 等. 急性下肢深静脉血栓患者危险因素分析. 中国普外基础与临床杂志, 2014, 21(10): 1264-1267.
|
13. |
Friera-Reyes A, Caballero P, Ruiz-Giménez N, et al. Usefulness of fast ELISA determination of D-dimer levels for diagnosing pulmonary embolism in an emergency room. Arch Bronconeumol, 2005, 41(9): 499-504.
|
14. |
Jennersjö CM, Fagerberg IH, Karlander SG, et al. Normal D-dimer concentration is a common finding in symptomatic outpatients with distal deep vein thrombosis. Blood Coagul Fibrinolysis, 2005, 16(7): 517-523.
|
15. |
李晓曦. 静脉血栓栓塞性疾病的诊断、治疗和 D-二聚体的检验. 中国血管外科杂志(电子版), 2013, 5(1): 11-13.
|
16. |
Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141(2 Suppl): e419S-e494S.
|
17. |
汪忠镐, 李震. 深静脉血栓治疗的商榷. 中国普外基础与临床杂志, 2012, 19(11): 1149-1151.
|
18. |
中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第二版). 中国血管外科杂志(电子版), 2013, 5(1): 23-26.
|
19. |
Wibur J, Shian B. Deep venous thrombosis and pulmonary embolism: current therapy. Am Fam Physician, 2017, 95(5): 295-302.
|
20. |
Jacobson BF, Louw S, Büller H, et al. Venous thromboembolism: prophylactic and therapeutic practice guideline. S Afr Med J, 2013, 103(4 Pt 2): 261-267.
|
21. |
Gonzalez-Fajardo JA, Arreba E, Castrodeza J, et al. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. J Vasc Surg, 1999, 30(2): 283-292.
|
22. |
Büller HR, Gent M, Gallus AS, et al. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med, 1997, 337(10): 657-662.
|
23. |
李文东, 李晓强, 钱爱民, 等. 下肢深静脉血栓形成治疗进展. 中国实用外科杂志, 2014, 34(12): 1190-1193.
|
24. |
Ma C, Zhang Y, Xu Q, et al. Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin. In J Hematol, 2012, 96(6): 719-728.
|
25. |
Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med, 2003, 348(10): 1425-1434.
|